Global Travelers Vaccines Market Growth 2026-2032
The global Travelers Vaccines market size is predicted to grow from US$ 4198 million in 2025 to US$ 7652 million in 2032; it is expected to grow at a CAGR of 9.1% from 2026 to 2032.
Travelers Vaccines refer to a range of preventive vaccines recommended or required for individuals traveling internationally for tourism, business, study, labor assignments, or humanitarian missions. These vaccines are designed to protect against infectious diseases prevalent in specific regions, such as yellow fever, typhoid fever, hepatitis A, hepatitis B, rabies, meningococcal disease, and cholera. Travelers vaccines include both routine immunization updates and destination-specific mandatory or recommended vaccinations, typically administered through specialized travel medicine clinics or international vaccination centers. Their core value lies in reducing cross-border transmission risks, safeguarding individual health, ensuring compliance with international entry regulations, and supporting global public health systems.In 2025, global Travelers Vaccine production reached approximately 780.18 million dosesand price is about 5.5 USD/dose.The average gross profit margin of this product is 70%.
The recovery of global cross-border mobility and the rebound of international tourism provide sustained growth momentum for the travelers vaccines market. Expanding business travel, overseas education, and labor mobility have made destination-specific health risk assessment an essential part of travel preparation. Strengthened public health controls and clearer vaccination certification requirements by destination countries further stimulate compliance-driven demand. Growing public health awareness and the emergence of premium outbound healthcare services are positioning travel medicine as an independent specialty segment. Improvements in digital appointment systems and vaccine cold chain infrastructure enhance accessibility and service efficiency.
Variations in vaccine approval and recommendation systems across countries complicate product registration and commercialization. Concerns about vaccine safety among certain traveler groups may affect uptake rates. Cold chain logistics and inventory management impose strict requirements on the supply chain, and improper handling may compromise product stability. Demand for certain vaccines is highly seasonal and region-specific, increasing forecasting complexity. In addition, global vaccine manufacturing capacity may be constrained by raw material availability and technological limitations, particularly during public health emergencies.
Downstream demand is concentrated in international travel clinics, entry-exit quarantine institutions, hospital immunization centers, and premium health screening facilities. Demand patterns are shifting from single mandatory vaccines to combination immunization programs, emphasizing personalized risk assessment and comprehensive health management. Long-term expatriates and high-risk occupational groups show increasing demand for booster doses and multi-dose vaccination schedules. Online health consultation and remote risk assessment services are becoming more prevalent, enabling earlier and more digitalized vaccination planning. Corporate group travel and international student populations represent important growth drivers.
The upstream segment of travelers vaccines includes key inputs such as antigen bulk materials, biological culture media, adjuvants, stabilizers, and packaging components. Vaccine production relies on high-standard bioreactor systems and aseptic filling technologies, with strict requirements for quality control and batch consistency. Cold chain equipment and temperature-controlled materials are essential to maintaining vaccine potency. As vaccine technologies advance toward recombinant proteins and combination formulations, the purity and complexity of upstream materials continue to increase. Supply chain stability and regulatory compliance capabilities are critical to ensuring continuous and reliable vaccine availability.
LP Information, Inc. (LPI) ' newest research report, the ?Travelers Vaccines Industry Forecast? looks at past sales and reviews total world Travelers Vaccines sales in 2025, providing a comprehensive analysis by region and market sector of projected Travelers Vaccines sales for 2026 through 2032. With Travelers Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Travelers Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Travelers Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Travelers Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Travelers Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Travelers Vaccines and breaks down the forecast by Type, by End Users, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Travelers Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Travelers Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Travelers Vaccines market?
What factors are driving Travelers Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Travelers Vaccines market opportunities vary by end market size?
How does Travelers Vaccines break out by Type, by End Users?
Travelers Vaccines refer to a range of preventive vaccines recommended or required for individuals traveling internationally for tourism, business, study, labor assignments, or humanitarian missions. These vaccines are designed to protect against infectious diseases prevalent in specific regions, such as yellow fever, typhoid fever, hepatitis A, hepatitis B, rabies, meningococcal disease, and cholera. Travelers vaccines include both routine immunization updates and destination-specific mandatory or recommended vaccinations, typically administered through specialized travel medicine clinics or international vaccination centers. Their core value lies in reducing cross-border transmission risks, safeguarding individual health, ensuring compliance with international entry regulations, and supporting global public health systems.In 2025, global Travelers Vaccine production reached approximately 780.18 million dosesand price is about 5.5 USD/dose.The average gross profit margin of this product is 70%.
The recovery of global cross-border mobility and the rebound of international tourism provide sustained growth momentum for the travelers vaccines market. Expanding business travel, overseas education, and labor mobility have made destination-specific health risk assessment an essential part of travel preparation. Strengthened public health controls and clearer vaccination certification requirements by destination countries further stimulate compliance-driven demand. Growing public health awareness and the emergence of premium outbound healthcare services are positioning travel medicine as an independent specialty segment. Improvements in digital appointment systems and vaccine cold chain infrastructure enhance accessibility and service efficiency.
Variations in vaccine approval and recommendation systems across countries complicate product registration and commercialization. Concerns about vaccine safety among certain traveler groups may affect uptake rates. Cold chain logistics and inventory management impose strict requirements on the supply chain, and improper handling may compromise product stability. Demand for certain vaccines is highly seasonal and region-specific, increasing forecasting complexity. In addition, global vaccine manufacturing capacity may be constrained by raw material availability and technological limitations, particularly during public health emergencies.
Downstream demand is concentrated in international travel clinics, entry-exit quarantine institutions, hospital immunization centers, and premium health screening facilities. Demand patterns are shifting from single mandatory vaccines to combination immunization programs, emphasizing personalized risk assessment and comprehensive health management. Long-term expatriates and high-risk occupational groups show increasing demand for booster doses and multi-dose vaccination schedules. Online health consultation and remote risk assessment services are becoming more prevalent, enabling earlier and more digitalized vaccination planning. Corporate group travel and international student populations represent important growth drivers.
The upstream segment of travelers vaccines includes key inputs such as antigen bulk materials, biological culture media, adjuvants, stabilizers, and packaging components. Vaccine production relies on high-standard bioreactor systems and aseptic filling technologies, with strict requirements for quality control and batch consistency. Cold chain equipment and temperature-controlled materials are essential to maintaining vaccine potency. As vaccine technologies advance toward recombinant proteins and combination formulations, the purity and complexity of upstream materials continue to increase. Supply chain stability and regulatory compliance capabilities are critical to ensuring continuous and reliable vaccine availability.
LP Information, Inc. (LPI) ' newest research report, the ?Travelers Vaccines Industry Forecast? looks at past sales and reviews total world Travelers Vaccines sales in 2025, providing a comprehensive analysis by region and market sector of projected Travelers Vaccines sales for 2026 through 2032. With Travelers Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Travelers Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Travelers Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Travelers Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Travelers Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Travelers Vaccines and breaks down the forecast by Type, by End Users, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Travelers Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Travelers Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Meningococcal Vaccine
- Japanese Encephalitis Vaccine
- Yellow Fever Vaccine
- Hepatitis Vaccine
- Cholera Vaccine
- Other
- Mandatory Vaccination
- Recommended Vaccination
- Routine Booster
- Travel Clinics
- Public Hospitals
- Private Providers
- Tourists
- Students
- Workers
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GSK
- Sanofi Pasteur
- Merck
- Pfizer
- CNBG
- Serum Institute
- Biokangtai
- NCPC
- Dynavax
- AIM Vaccine
- KM Biologics
- LG Life Sciences
What is the 10-year outlook for the global Travelers Vaccines market?
What factors are driving Travelers Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Travelers Vaccines market opportunities vary by end market size?
How does Travelers Vaccines break out by Type, by End Users?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Travelers Vaccines Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Travelers Vaccines by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Travelers Vaccines by Country/Region, 2021, 2025 & 2032
2.2 Travelers Vaccines Segment by Type
2.2.1 Meningococcal Vaccine
2.2.2 Japanese Encephalitis Vaccine
2.2.3 Yellow Fever Vaccine
2.2.4 Hepatitis Vaccine
2.2.5 Cholera Vaccine
2.2.6 Other
2.2.7 Travelers Vaccines Sales by Type
2.2.7.1 Global Travelers Vaccines Sales Market Share by Type (2021-2026)
2.2.7.2 Global Travelers Vaccines Revenue and Market Share by Type (2021-2026)
2.2.7.3 Global Travelers Vaccines Sale Price by Type (2021-2026)
2.3 Travelers Vaccines Segment by Vaccination Purpose
2.3.1 Mandatory Vaccination
2.3.2 Recommended Vaccination
2.3.3 Routine Booster
2.3.4 Travelers Vaccines Sales by Vaccination Purpose
2.3.4.1 Global Travelers Vaccines Sales Market Share by Vaccination Purpose (2021-2026)
2.3.4.2 Global Travelers Vaccines Revenue and Market Share by Vaccination Purpose (2021-2026)
2.3.4.3 Global Travelers Vaccines Sale Price by Vaccination Purpose (2021-2026)
2.4 Travelers Vaccines Segment by End Channel
2.4.1 Travel Clinics
2.4.2 Public Hospitals
2.4.3 Private Providers
2.4.4 Travelers Vaccines Sales by End Channel
2.4.4.1 Global Travelers Vaccines Sales Market Share by End Channel (2021-2026)
2.4.4.2 Global Travelers Vaccines Revenue and Market Share by End Channel (2021-2026)
2.4.4.3 Global Travelers Vaccines Sale Price by End Channel (2021-2026)
2.5 Travelers Vaccines Segment by End Users
2.5.1 Tourists
2.5.2 Students
2.5.3 Workers
2.5.4 Others
2.5.5 Travelers Vaccines Sales by End Users
2.5.5.1 Global Travelers Vaccines Sale Market Share by End Users (2021-2026)
2.5.5.2 Global Travelers Vaccines Revenue and Market Share by End Users (2021-2026)
2.5.5.3 Global Travelers Vaccines Sale Price by End Users (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Travelers Vaccines Breakdown Data by Company
3.1.1 Global Travelers Vaccines Annual Sales by Company (2021-2026)
3.1.2 Global Travelers Vaccines Sales Market Share by Company (2021-2026)
3.2 Global Travelers Vaccines Annual Revenue by Company (2021-2026)
3.2.1 Global Travelers Vaccines Revenue by Company (2021-2026)
3.2.2 Global Travelers Vaccines Revenue Market Share by Company (2021-2026)
3.3 Global Travelers Vaccines Sale Price by Company
3.4 Key Manufacturers Travelers Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Travelers Vaccines Product Location Distribution
3.4.2 Players Travelers Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TRAVELERS VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Travelers Vaccines Market Size by Geographic Region (2021-2026)
4.1.1 Global Travelers Vaccines Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Travelers Vaccines Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Travelers Vaccines Market Size by Country/Region (2021-2026)
4.2.1 Global Travelers Vaccines Annual Sales by Country/Region (2021-2026)
4.2.2 Global Travelers Vaccines Annual Revenue by Country/Region (2021-2026)
4.3 Americas Travelers Vaccines Sales Growth
4.4 APAC Travelers Vaccines Sales Growth
4.5 Europe Travelers Vaccines Sales Growth
4.6 Middle East & Africa Travelers Vaccines Sales Growth
5 AMERICAS
5.1 Americas Travelers Vaccines Sales by Country
5.1.1 Americas Travelers Vaccines Sales by Country (2021-2026)
5.1.2 Americas Travelers Vaccines Revenue by Country (2021-2026)
5.2 Americas Travelers Vaccines Sales by Type (2021-2026)
5.3 Americas Travelers Vaccines Sales by End Users (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Travelers Vaccines Sales by Region
6.1.1 APAC Travelers Vaccines Sales by Region (2021-2026)
6.1.2 APAC Travelers Vaccines Revenue by Region (2021-2026)
6.2 APAC Travelers Vaccines Sales by Type (2021-2026)
6.3 APAC Travelers Vaccines Sales by End Users (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Travelers Vaccines by Country
7.1.1 Europe Travelers Vaccines Sales by Country (2021-2026)
7.1.2 Europe Travelers Vaccines Revenue by Country (2021-2026)
7.2 Europe Travelers Vaccines Sales by Type (2021-2026)
7.3 Europe Travelers Vaccines Sales by End Users (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Travelers Vaccines by Country
8.1.1 Middle East & Africa Travelers Vaccines Sales by Country (2021-2026)
8.1.2 Middle East & Africa Travelers Vaccines Revenue by Country (2021-2026)
8.2 Middle East & Africa Travelers Vaccines Sales by Type (2021-2026)
8.3 Middle East & Africa Travelers Vaccines Sales by End Users (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Travelers Vaccines
10.3 Manufacturing Process Analysis of Travelers Vaccines
10.4 Industry Chain Structure of Travelers Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Travelers Vaccines Distributors
11.3 Travelers Vaccines Customer
12 WORLD FORECAST REVIEW FOR TRAVELERS VACCINES BY GEOGRAPHIC REGION
12.1 Global Travelers Vaccines Market Size Forecast by Region
12.1.1 Global Travelers Vaccines Forecast by Region (2027-2032)
12.1.2 Global Travelers Vaccines Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Travelers Vaccines Forecast by Type (2027-2032)
12.7 Global Travelers Vaccines Forecast by End Users (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Travelers Vaccines Product Portfolios and Specifications
13.1.3 GSK Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Sanofi Pasteur
13.2.1 Sanofi Pasteur Company Information
13.2.2 Sanofi Pasteur Travelers Vaccines Product Portfolios and Specifications
13.2.3 Sanofi Pasteur Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sanofi Pasteur Main Business Overview
13.2.5 Sanofi Pasteur Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Travelers Vaccines Product Portfolios and Specifications
13.3.3 Merck Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Travelers Vaccines Product Portfolios and Specifications
13.4.3 Pfizer Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 CNBG
13.5.1 CNBG Company Information
13.5.2 CNBG Travelers Vaccines Product Portfolios and Specifications
13.5.3 CNBG Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 CNBG Main Business Overview
13.5.5 CNBG Latest Developments
13.6 Serum Institute
13.6.1 Serum Institute Company Information
13.6.2 Serum Institute Travelers Vaccines Product Portfolios and Specifications
13.6.3 Serum Institute Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Serum Institute Main Business Overview
13.6.5 Serum Institute Latest Developments
13.7 Biokangtai
13.7.1 Biokangtai Company Information
13.7.2 Biokangtai Travelers Vaccines Product Portfolios and Specifications
13.7.3 Biokangtai Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Biokangtai Main Business Overview
13.7.5 Biokangtai Latest Developments
13.8 NCPC
13.8.1 NCPC Company Information
13.8.2 NCPC Travelers Vaccines Product Portfolios and Specifications
13.8.3 NCPC Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 NCPC Main Business Overview
13.8.5 NCPC Latest Developments
13.9 Dynavax
13.9.1 Dynavax Company Information
13.9.2 Dynavax Travelers Vaccines Product Portfolios and Specifications
13.9.3 Dynavax Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Dynavax Main Business Overview
13.9.5 Dynavax Latest Developments
13.10 AIM Vaccine
13.10.1 AIM Vaccine Company Information
13.10.2 AIM Vaccine Travelers Vaccines Product Portfolios and Specifications
13.10.3 AIM Vaccine Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 AIM Vaccine Main Business Overview
13.10.5 AIM Vaccine Latest Developments
13.11 KM Biologics
13.11.1 KM Biologics Company Information
13.11.2 KM Biologics Travelers Vaccines Product Portfolios and Specifications
13.11.3 KM Biologics Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 KM Biologics Main Business Overview
13.11.5 KM Biologics Latest Developments
13.12 LG Life Sciences
13.12.1 LG Life Sciences Company Information
13.12.2 LG Life Sciences Travelers Vaccines Product Portfolios and Specifications
13.12.3 LG Life Sciences Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 LG Life Sciences Main Business Overview
13.12.5 LG Life Sciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Travelers Vaccines Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Travelers Vaccines by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Travelers Vaccines by Country/Region, 2021, 2025 & 2032
2.2 Travelers Vaccines Segment by Type
2.2.1 Meningococcal Vaccine
2.2.2 Japanese Encephalitis Vaccine
2.2.3 Yellow Fever Vaccine
2.2.4 Hepatitis Vaccine
2.2.5 Cholera Vaccine
2.2.6 Other
2.2.7 Travelers Vaccines Sales by Type
2.2.7.1 Global Travelers Vaccines Sales Market Share by Type (2021-2026)
2.2.7.2 Global Travelers Vaccines Revenue and Market Share by Type (2021-2026)
2.2.7.3 Global Travelers Vaccines Sale Price by Type (2021-2026)
2.3 Travelers Vaccines Segment by Vaccination Purpose
2.3.1 Mandatory Vaccination
2.3.2 Recommended Vaccination
2.3.3 Routine Booster
2.3.4 Travelers Vaccines Sales by Vaccination Purpose
2.3.4.1 Global Travelers Vaccines Sales Market Share by Vaccination Purpose (2021-2026)
2.3.4.2 Global Travelers Vaccines Revenue and Market Share by Vaccination Purpose (2021-2026)
2.3.4.3 Global Travelers Vaccines Sale Price by Vaccination Purpose (2021-2026)
2.4 Travelers Vaccines Segment by End Channel
2.4.1 Travel Clinics
2.4.2 Public Hospitals
2.4.3 Private Providers
2.4.4 Travelers Vaccines Sales by End Channel
2.4.4.1 Global Travelers Vaccines Sales Market Share by End Channel (2021-2026)
2.4.4.2 Global Travelers Vaccines Revenue and Market Share by End Channel (2021-2026)
2.4.4.3 Global Travelers Vaccines Sale Price by End Channel (2021-2026)
2.5 Travelers Vaccines Segment by End Users
2.5.1 Tourists
2.5.2 Students
2.5.3 Workers
2.5.4 Others
2.5.5 Travelers Vaccines Sales by End Users
2.5.5.1 Global Travelers Vaccines Sale Market Share by End Users (2021-2026)
2.5.5.2 Global Travelers Vaccines Revenue and Market Share by End Users (2021-2026)
2.5.5.3 Global Travelers Vaccines Sale Price by End Users (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Travelers Vaccines Breakdown Data by Company
3.1.1 Global Travelers Vaccines Annual Sales by Company (2021-2026)
3.1.2 Global Travelers Vaccines Sales Market Share by Company (2021-2026)
3.2 Global Travelers Vaccines Annual Revenue by Company (2021-2026)
3.2.1 Global Travelers Vaccines Revenue by Company (2021-2026)
3.2.2 Global Travelers Vaccines Revenue Market Share by Company (2021-2026)
3.3 Global Travelers Vaccines Sale Price by Company
3.4 Key Manufacturers Travelers Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Travelers Vaccines Product Location Distribution
3.4.2 Players Travelers Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TRAVELERS VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Travelers Vaccines Market Size by Geographic Region (2021-2026)
4.1.1 Global Travelers Vaccines Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Travelers Vaccines Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Travelers Vaccines Market Size by Country/Region (2021-2026)
4.2.1 Global Travelers Vaccines Annual Sales by Country/Region (2021-2026)
4.2.2 Global Travelers Vaccines Annual Revenue by Country/Region (2021-2026)
4.3 Americas Travelers Vaccines Sales Growth
4.4 APAC Travelers Vaccines Sales Growth
4.5 Europe Travelers Vaccines Sales Growth
4.6 Middle East & Africa Travelers Vaccines Sales Growth
5 AMERICAS
5.1 Americas Travelers Vaccines Sales by Country
5.1.1 Americas Travelers Vaccines Sales by Country (2021-2026)
5.1.2 Americas Travelers Vaccines Revenue by Country (2021-2026)
5.2 Americas Travelers Vaccines Sales by Type (2021-2026)
5.3 Americas Travelers Vaccines Sales by End Users (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Travelers Vaccines Sales by Region
6.1.1 APAC Travelers Vaccines Sales by Region (2021-2026)
6.1.2 APAC Travelers Vaccines Revenue by Region (2021-2026)
6.2 APAC Travelers Vaccines Sales by Type (2021-2026)
6.3 APAC Travelers Vaccines Sales by End Users (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Travelers Vaccines by Country
7.1.1 Europe Travelers Vaccines Sales by Country (2021-2026)
7.1.2 Europe Travelers Vaccines Revenue by Country (2021-2026)
7.2 Europe Travelers Vaccines Sales by Type (2021-2026)
7.3 Europe Travelers Vaccines Sales by End Users (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Travelers Vaccines by Country
8.1.1 Middle East & Africa Travelers Vaccines Sales by Country (2021-2026)
8.1.2 Middle East & Africa Travelers Vaccines Revenue by Country (2021-2026)
8.2 Middle East & Africa Travelers Vaccines Sales by Type (2021-2026)
8.3 Middle East & Africa Travelers Vaccines Sales by End Users (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Travelers Vaccines
10.3 Manufacturing Process Analysis of Travelers Vaccines
10.4 Industry Chain Structure of Travelers Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Travelers Vaccines Distributors
11.3 Travelers Vaccines Customer
12 WORLD FORECAST REVIEW FOR TRAVELERS VACCINES BY GEOGRAPHIC REGION
12.1 Global Travelers Vaccines Market Size Forecast by Region
12.1.1 Global Travelers Vaccines Forecast by Region (2027-2032)
12.1.2 Global Travelers Vaccines Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Travelers Vaccines Forecast by Type (2027-2032)
12.7 Global Travelers Vaccines Forecast by End Users (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Travelers Vaccines Product Portfolios and Specifications
13.1.3 GSK Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Sanofi Pasteur
13.2.1 Sanofi Pasteur Company Information
13.2.2 Sanofi Pasteur Travelers Vaccines Product Portfolios and Specifications
13.2.3 Sanofi Pasteur Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sanofi Pasteur Main Business Overview
13.2.5 Sanofi Pasteur Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Travelers Vaccines Product Portfolios and Specifications
13.3.3 Merck Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Travelers Vaccines Product Portfolios and Specifications
13.4.3 Pfizer Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 CNBG
13.5.1 CNBG Company Information
13.5.2 CNBG Travelers Vaccines Product Portfolios and Specifications
13.5.3 CNBG Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 CNBG Main Business Overview
13.5.5 CNBG Latest Developments
13.6 Serum Institute
13.6.1 Serum Institute Company Information
13.6.2 Serum Institute Travelers Vaccines Product Portfolios and Specifications
13.6.3 Serum Institute Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Serum Institute Main Business Overview
13.6.5 Serum Institute Latest Developments
13.7 Biokangtai
13.7.1 Biokangtai Company Information
13.7.2 Biokangtai Travelers Vaccines Product Portfolios and Specifications
13.7.3 Biokangtai Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Biokangtai Main Business Overview
13.7.5 Biokangtai Latest Developments
13.8 NCPC
13.8.1 NCPC Company Information
13.8.2 NCPC Travelers Vaccines Product Portfolios and Specifications
13.8.3 NCPC Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 NCPC Main Business Overview
13.8.5 NCPC Latest Developments
13.9 Dynavax
13.9.1 Dynavax Company Information
13.9.2 Dynavax Travelers Vaccines Product Portfolios and Specifications
13.9.3 Dynavax Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Dynavax Main Business Overview
13.9.5 Dynavax Latest Developments
13.10 AIM Vaccine
13.10.1 AIM Vaccine Company Information
13.10.2 AIM Vaccine Travelers Vaccines Product Portfolios and Specifications
13.10.3 AIM Vaccine Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 AIM Vaccine Main Business Overview
13.10.5 AIM Vaccine Latest Developments
13.11 KM Biologics
13.11.1 KM Biologics Company Information
13.11.2 KM Biologics Travelers Vaccines Product Portfolios and Specifications
13.11.3 KM Biologics Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 KM Biologics Main Business Overview
13.11.5 KM Biologics Latest Developments
13.12 LG Life Sciences
13.12.1 LG Life Sciences Company Information
13.12.2 LG Life Sciences Travelers Vaccines Product Portfolios and Specifications
13.12.3 LG Life Sciences Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 LG Life Sciences Main Business Overview
13.12.5 LG Life Sciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Travelers Vaccines Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Travelers Vaccines Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Meningococcal Vaccine
Table 4. Major Players of Japanese Encephalitis Vaccine
Table 5. Major Players of Yellow Fever Vaccine
Table 6. Major Players of Hepatitis Vaccine
Table 7. Major Players of Cholera Vaccine
Table 8. Major Players of Other
Table 9. Global Travelers Vaccines Sales by Type (2021-2026) & (K Doses)
Table 10. Global Travelers Vaccines Sales Market Share by Type (2021-2026)
Table 11. Global Travelers Vaccines Revenue by Type (2021-2026) & ($ million)
Table 12. Global Travelers Vaccines Revenue Market Share by Type (2021-2026)
Table 13. Global Travelers Vaccines Sale Price by Type (2021-2026) & (USD/Dose)
Table 14. Major Players of Mandatory Vaccination
Table 15. Major Players of Recommended Vaccination
Table 16. Major Players of Routine Booster
Table 17. Global Travelers Vaccines Sales by Vaccination Purpose (2021-2026) & (K Doses)
Table 18. Global Travelers Vaccines Sales Market Share by Vaccination Purpose (2021-2026)
Table 19. Global Travelers Vaccines Revenue by Vaccination Purpose (2021-2026) & ($ million)
Table 20. Global Travelers Vaccines Revenue Market Share by Vaccination Purpose (2021-2026)
Table 21. Global Travelers Vaccines Sale Price by Vaccination Purpose (2021-2026) & (USD/Dose)
Table 22. Major Players of Travel Clinics
Table 23. Major Players of Public Hospitals
Table 24. Major Players of Private Providers
Table 25. Global Travelers Vaccines Sales by End Channel (2021-2026) & (K Doses)
Table 26. Global Travelers Vaccines Sales Market Share by End Channel (2021-2026)
Table 27. Global Travelers Vaccines Revenue by End Channel (2021-2026) & ($ million)
Table 28. Global Travelers Vaccines Revenue Market Share by End Channel (2021-2026)
Table 29. Global Travelers Vaccines Sale Price by End Channel (2021-2026) & (USD/Dose)
Table 30. Global Travelers Vaccines Sale by End Users (2021-2026) & (K Doses)
Table 31. Global Travelers Vaccines Sale Market Share by End Users (2021-2026)
Table 32. Global Travelers Vaccines Revenue by End Users (2021-2026) & ($ million)
Table 33. Global Travelers Vaccines Revenue Market Share by End Users (2021-2026)
Table 34. Global Travelers Vaccines Sale Price by End Users (2021-2026) & (USD/Dose)
Table 35. Global Travelers Vaccines Sales by Company (2021-2026) & (K Doses)
Table 36. Global Travelers Vaccines Sales Market Share by Company (2021-2026)
Table 37. Global Travelers Vaccines Revenue by Company (2021-2026) & ($ millions)
Table 38. Global Travelers Vaccines Revenue Market Share by Company (2021-2026)
Table 39. Global Travelers Vaccines Sale Price by Company (2021-2026) & (USD/Dose)
Table 40. Key Manufacturers Travelers Vaccines Producing Area Distribution and Sales Area
Table 41. Players Travelers Vaccines Products Offered
Table 42. Travelers Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 43. New Products and Potential Entrants
Table 44. Market M&A Activity & Strategy
Table 45. Global Travelers Vaccines Sales by Geographic Region (2021-2026) & (K Doses)
Table 46. Global Travelers Vaccines Sales Market Share Geographic Region (2021-2026)
Table 47. Global Travelers Vaccines Revenue by Geographic Region (2021-2026) & ($ millions)
Table 48. Global Travelers Vaccines Revenue Market Share by Geographic Region (2021-2026)
Table 49. Global Travelers Vaccines Sales by Country/Region (2021-2026) & (K Doses)
Table 50. Global Travelers Vaccines Sales Market Share by Country/Region (2021-2026)
Table 51. Global Travelers Vaccines Revenue by Country/Region (2021-2026) & ($ millions)
Table 52. Global Travelers Vaccines Revenue Market Share by Country/Region (2021-2026)
Table 53. Americas Travelers Vaccines Sales by Country (2021-2026) & (K Doses)
Table 54. Americas Travelers Vaccines Sales Market Share by Country (2021-2026)
Table 55. Americas Travelers Vaccines Revenue by Country (2021-2026) & ($ millions)
Table 56. Americas Travelers Vaccines Sales by Type (2021-2026) & (K Doses)
Table 57. Americas Travelers Vaccines Sales by End Users (2021-2026) & (K Doses)
Table 58. APAC Travelers Vaccines Sales by Region (2021-2026) & (K Doses)
Table 59. APAC Travelers Vaccines Sales Market Share by Region (2021-2026)
Table 60. APAC Travelers Vaccines Revenue by Region (2021-2026) & ($ millions)
Table 61. APAC Travelers Vaccines Sales by Type (2021-2026) & (K Doses)
Table 62. APAC Travelers Vaccines Sales by End Users (2021-2026) & (K Doses)
Table 63. Europe Travelers Vaccines Sales by Country (2021-2026) & (K Doses)
Table 64. Europe Travelers Vaccines Revenue by Country (2021-2026) & ($ millions)
Table 65. Europe Travelers Vaccines Sales by Type (2021-2026) & (K Doses)
Table 66. Europe Travelers Vaccines Sales by End Users (2021-2026) & (K Doses)
Table 67. Middle East & Africa Travelers Vaccines Sales by Country (2021-2026) & (K Doses)
Table 68. Middle East & Africa Travelers Vaccines Revenue Market Share by Country (2021-2026)
Table 69. Middle East & Africa Travelers Vaccines Sales by Type (2021-2026) & (K Doses)
Table 70. Middle East & Africa Travelers Vaccines Sales by End Users (2021-2026) & (K Doses)
Table 71. Key Market Drivers & Growth Opportunities of Travelers Vaccines
Table 72. Key Market Challenges & Risks of Travelers Vaccines
Table 73. Key Industry Trends of Travelers Vaccines
Table 74. Travelers Vaccines Raw Material
Table 75. Key Suppliers of Raw Materials
Table 76. Travelers Vaccines Distributors List
Table 77. Travelers Vaccines Customer List
Table 78. Global Travelers Vaccines Sales Forecast by Region (2027-2032) & (K Doses)
Table 79. Global Travelers Vaccines Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Americas Travelers Vaccines Sales Forecast by Country (2027-2032) & (K Doses)
Table 81. Americas Travelers Vaccines Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. APAC Travelers Vaccines Sales Forecast by Region (2027-2032) & (K Doses)
Table 83. APAC Travelers Vaccines Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 84. Europe Travelers Vaccines Sales Forecast by Country (2027-2032) & (K Doses)
Table 85. Europe Travelers Vaccines Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Middle East & Africa Travelers Vaccines Sales Forecast by Country (2027-2032) & (K Doses)
Table 87. Middle East & Africa Travelers Vaccines Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Global Travelers Vaccines Sales Forecast by Type (2027-2032) & (K Doses)
Table 89. Global Travelers Vaccines Revenue Forecast by Type (2027-2032) & ($ millions)
Table 90. Global Travelers Vaccines Sales Forecast by End Users (2027-2032) & (K Doses)
Table 91. Global Travelers Vaccines Revenue Forecast by End Users (2027-2032) & ($ millions)
Table 92. GSK Basic Information, Travelers Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. GSK Travelers Vaccines Product Portfolios and Specifications
Table 94. GSK Travelers Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2021-2026)
Table 95. GSK Main Business
Table 96. GSK Latest Developments
Table 97. Sanofi Pasteur Basic Information, Travelers Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 98. Sanofi Pasteur Travelers Vaccines Product Portfolios and Specifications
Table 99. Sanofi Pasteur Travelers Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2021-2026)
Table 100. Sanofi Pasteur Main Business
Table 101. Sanofi Pasteur Latest Developments
Table 102. Merck Basic Information, Travelers Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 103. Merck Travelers Vaccines Product Portfolios and Specifications
Table 104. Merck Travelers Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2021-2026)
Table 105. Merck Main Business
Table 106. Merck Latest Developments
Table 107. Pfizer Basic Information, Travelers Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 108. Pfizer Travelers Vaccines Product Portfolios and Specifications
Table 109. Pfizer Travelers Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2021-2026)
Table 110. Pfizer Main Business
Table 111. Pfizer Latest Developments
Table 112. CNBG Basic Information, Travelers Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 113. CNBG Travelers Vaccines Product Portfolios and Specifications
Table 114. CNBG Travelers Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2021-2026)
Table 115. CNBG Main Business
Table 116. CNBG Latest Developments
Table 117. Serum Institute Basic Information, Travelers Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 118. Serum Institute Travelers Vaccines Product Portfolios and Specifications
Table 119. Serum Institute Travelers Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2021-2026)
Table 120. Serum Institute Main Business
Table 121. Serum Institute Latest Developments
Table 122. Biokangtai Basic Information, Travelers Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 123. Biokangtai Travelers Vaccines Product Portfolios and Specifications
Table 124. Biokangtai Travelers Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2021-2026)
Table 125. Biokangtai Main Business
Table 126. Biokangtai Latest Developments
Table 127. NCPC Basic Information, Travelers Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 128. NCPC Travelers Vaccines Product Portfolios and Specifications
Table 129. NCPC Travelers Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2021-2026)
Table 130. NCPC Main Business
Table 131. NCPC Latest Developments
Table 132. Dynavax Basic Information, Travelers Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 133. Dynavax Travelers Vaccines Product Portfolios and Specifications
Table 134. Dynavax Travelers Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2021-2026)
Table 135. Dynavax Main Business
Table 136. Dynavax Latest Developments
Table 137. AIM Vaccine Basic Information, Travelers Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 138. AIM Vaccine Travelers Vaccines Product Portfolios and Specifications
Table 139. AIM Vaccine Travelers Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2021-2026)
Table 140. AIM Vaccine Main Business
Table 141. AIM Vaccine Latest Developments
Table 142. KM Biologics Basic Information, Travelers Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 143. KM Biologics Travelers Vaccines Product Portfolios and Specifications
Table 144. KM Biologics Travelers Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2021-2026)
Table 145. KM Biologics Main Business
Table 146. KM Biologics Latest Developments
Table 147. LG Life Sciences Basic Information, Travelers Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 148. LG Life Sciences Travelers Vaccines Product Portfolios and Specifications
Table 149. LG Life Sciences Travelers Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2021-2026)
Table 150. LG Life Sciences Main Business
Table 151. LG Life Sciences Latest Developments
Table 1. Travelers Vaccines Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Travelers Vaccines Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Meningococcal Vaccine
Table 4. Major Players of Japanese Encephalitis Vaccine
Table 5. Major Players of Yellow Fever Vaccine
Table 6. Major Players of Hepatitis Vaccine
Table 7. Major Players of Cholera Vaccine
Table 8. Major Players of Other
Table 9. Global Travelers Vaccines Sales by Type (2021-2026) & (K Doses)
Table 10. Global Travelers Vaccines Sales Market Share by Type (2021-2026)
Table 11. Global Travelers Vaccines Revenue by Type (2021-2026) & ($ million)
Table 12. Global Travelers Vaccines Revenue Market Share by Type (2021-2026)
Table 13. Global Travelers Vaccines Sale Price by Type (2021-2026) & (USD/Dose)
Table 14. Major Players of Mandatory Vaccination
Table 15. Major Players of Recommended Vaccination
Table 16. Major Players of Routine Booster
Table 17. Global Travelers Vaccines Sales by Vaccination Purpose (2021-2026) & (K Doses)
Table 18. Global Travelers Vaccines Sales Market Share by Vaccination Purpose (2021-2026)
Table 19. Global Travelers Vaccines Revenue by Vaccination Purpose (2021-2026) & ($ million)
Table 20. Global Travelers Vaccines Revenue Market Share by Vaccination Purpose (2021-2026)
Table 21. Global Travelers Vaccines Sale Price by Vaccination Purpose (2021-2026) & (USD/Dose)
Table 22. Major Players of Travel Clinics
Table 23. Major Players of Public Hospitals
Table 24. Major Players of Private Providers
Table 25. Global Travelers Vaccines Sales by End Channel (2021-2026) & (K Doses)
Table 26. Global Travelers Vaccines Sales Market Share by End Channel (2021-2026)
Table 27. Global Travelers Vaccines Revenue by End Channel (2021-2026) & ($ million)
Table 28. Global Travelers Vaccines Revenue Market Share by End Channel (2021-2026)
Table 29. Global Travelers Vaccines Sale Price by End Channel (2021-2026) & (USD/Dose)
Table 30. Global Travelers Vaccines Sale by End Users (2021-2026) & (K Doses)
Table 31. Global Travelers Vaccines Sale Market Share by End Users (2021-2026)
Table 32. Global Travelers Vaccines Revenue by End Users (2021-2026) & ($ million)
Table 33. Global Travelers Vaccines Revenue Market Share by End Users (2021-2026)
Table 34. Global Travelers Vaccines Sale Price by End Users (2021-2026) & (USD/Dose)
Table 35. Global Travelers Vaccines Sales by Company (2021-2026) & (K Doses)
Table 36. Global Travelers Vaccines Sales Market Share by Company (2021-2026)
Table 37. Global Travelers Vaccines Revenue by Company (2021-2026) & ($ millions)
Table 38. Global Travelers Vaccines Revenue Market Share by Company (2021-2026)
Table 39. Global Travelers Vaccines Sale Price by Company (2021-2026) & (USD/Dose)
Table 40. Key Manufacturers Travelers Vaccines Producing Area Distribution and Sales Area
Table 41. Players Travelers Vaccines Products Offered
Table 42. Travelers Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 43. New Products and Potential Entrants
Table 44. Market M&A Activity & Strategy
Table 45. Global Travelers Vaccines Sales by Geographic Region (2021-2026) & (K Doses)
Table 46. Global Travelers Vaccines Sales Market Share Geographic Region (2021-2026)
Table 47. Global Travelers Vaccines Revenue by Geographic Region (2021-2026) & ($ millions)
Table 48. Global Travelers Vaccines Revenue Market Share by Geographic Region (2021-2026)
Table 49. Global Travelers Vaccines Sales by Country/Region (2021-2026) & (K Doses)
Table 50. Global Travelers Vaccines Sales Market Share by Country/Region (2021-2026)
Table 51. Global Travelers Vaccines Revenue by Country/Region (2021-2026) & ($ millions)
Table 52. Global Travelers Vaccines Revenue Market Share by Country/Region (2021-2026)
Table 53. Americas Travelers Vaccines Sales by Country (2021-2026) & (K Doses)
Table 54. Americas Travelers Vaccines Sales Market Share by Country (2021-2026)
Table 55. Americas Travelers Vaccines Revenue by Country (2021-2026) & ($ millions)
Table 56. Americas Travelers Vaccines Sales by Type (2021-2026) & (K Doses)
Table 57. Americas Travelers Vaccines Sales by End Users (2021-2026) & (K Doses)
Table 58. APAC Travelers Vaccines Sales by Region (2021-2026) & (K Doses)
Table 59. APAC Travelers Vaccines Sales Market Share by Region (2021-2026)
Table 60. APAC Travelers Vaccines Revenue by Region (2021-2026) & ($ millions)
Table 61. APAC Travelers Vaccines Sales by Type (2021-2026) & (K Doses)
Table 62. APAC Travelers Vaccines Sales by End Users (2021-2026) & (K Doses)
Table 63. Europe Travelers Vaccines Sales by Country (2021-2026) & (K Doses)
Table 64. Europe Travelers Vaccines Revenue by Country (2021-2026) & ($ millions)
Table 65. Europe Travelers Vaccines Sales by Type (2021-2026) & (K Doses)
Table 66. Europe Travelers Vaccines Sales by End Users (2021-2026) & (K Doses)
Table 67. Middle East & Africa Travelers Vaccines Sales by Country (2021-2026) & (K Doses)
Table 68. Middle East & Africa Travelers Vaccines Revenue Market Share by Country (2021-2026)
Table 69. Middle East & Africa Travelers Vaccines Sales by Type (2021-2026) & (K Doses)
Table 70. Middle East & Africa Travelers Vaccines Sales by End Users (2021-2026) & (K Doses)
Table 71. Key Market Drivers & Growth Opportunities of Travelers Vaccines
Table 72. Key Market Challenges & Risks of Travelers Vaccines
Table 73. Key Industry Trends of Travelers Vaccines
Table 74. Travelers Vaccines Raw Material
Table 75. Key Suppliers of Raw Materials
Table 76. Travelers Vaccines Distributors List
Table 77. Travelers Vaccines Customer List
Table 78. Global Travelers Vaccines Sales Forecast by Region (2027-2032) & (K Doses)
Table 79. Global Travelers Vaccines Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Americas Travelers Vaccines Sales Forecast by Country (2027-2032) & (K Doses)
Table 81. Americas Travelers Vaccines Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. APAC Travelers Vaccines Sales Forecast by Region (2027-2032) & (K Doses)
Table 83. APAC Travelers Vaccines Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 84. Europe Travelers Vaccines Sales Forecast by Country (2027-2032) & (K Doses)
Table 85. Europe Travelers Vaccines Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Middle East & Africa Travelers Vaccines Sales Forecast by Country (2027-2032) & (K Doses)
Table 87. Middle East & Africa Travelers Vaccines Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Global Travelers Vaccines Sales Forecast by Type (2027-2032) & (K Doses)
Table 89. Global Travelers Vaccines Revenue Forecast by Type (2027-2032) & ($ millions)
Table 90. Global Travelers Vaccines Sales Forecast by End Users (2027-2032) & (K Doses)
Table 91. Global Travelers Vaccines Revenue Forecast by End Users (2027-2032) & ($ millions)
Table 92. GSK Basic Information, Travelers Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. GSK Travelers Vaccines Product Portfolios and Specifications
Table 94. GSK Travelers Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2021-2026)
Table 95. GSK Main Business
Table 96. GSK Latest Developments
Table 97. Sanofi Pasteur Basic Information, Travelers Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 98. Sanofi Pasteur Travelers Vaccines Product Portfolios and Specifications
Table 99. Sanofi Pasteur Travelers Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2021-2026)
Table 100. Sanofi Pasteur Main Business
Table 101. Sanofi Pasteur Latest Developments
Table 102. Merck Basic Information, Travelers Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 103. Merck Travelers Vaccines Product Portfolios and Specifications
Table 104. Merck Travelers Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2021-2026)
Table 105. Merck Main Business
Table 106. Merck Latest Developments
Table 107. Pfizer Basic Information, Travelers Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 108. Pfizer Travelers Vaccines Product Portfolios and Specifications
Table 109. Pfizer Travelers Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2021-2026)
Table 110. Pfizer Main Business
Table 111. Pfizer Latest Developments
Table 112. CNBG Basic Information, Travelers Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 113. CNBG Travelers Vaccines Product Portfolios and Specifications
Table 114. CNBG Travelers Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2021-2026)
Table 115. CNBG Main Business
Table 116. CNBG Latest Developments
Table 117. Serum Institute Basic Information, Travelers Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 118. Serum Institute Travelers Vaccines Product Portfolios and Specifications
Table 119. Serum Institute Travelers Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2021-2026)
Table 120. Serum Institute Main Business
Table 121. Serum Institute Latest Developments
Table 122. Biokangtai Basic Information, Travelers Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 123. Biokangtai Travelers Vaccines Product Portfolios and Specifications
Table 124. Biokangtai Travelers Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2021-2026)
Table 125. Biokangtai Main Business
Table 126. Biokangtai Latest Developments
Table 127. NCPC Basic Information, Travelers Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 128. NCPC Travelers Vaccines Product Portfolios and Specifications
Table 129. NCPC Travelers Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2021-2026)
Table 130. NCPC Main Business
Table 131. NCPC Latest Developments
Table 132. Dynavax Basic Information, Travelers Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 133. Dynavax Travelers Vaccines Product Portfolios and Specifications
Table 134. Dynavax Travelers Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2021-2026)
Table 135. Dynavax Main Business
Table 136. Dynavax Latest Developments
Table 137. AIM Vaccine Basic Information, Travelers Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 138. AIM Vaccine Travelers Vaccines Product Portfolios and Specifications
Table 139. AIM Vaccine Travelers Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2021-2026)
Table 140. AIM Vaccine Main Business
Table 141. AIM Vaccine Latest Developments
Table 142. KM Biologics Basic Information, Travelers Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 143. KM Biologics Travelers Vaccines Product Portfolios and Specifications
Table 144. KM Biologics Travelers Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2021-2026)
Table 145. KM Biologics Main Business
Table 146. KM Biologics Latest Developments
Table 147. LG Life Sciences Basic Information, Travelers Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 148. LG Life Sciences Travelers Vaccines Product Portfolios and Specifications
Table 149. LG Life Sciences Travelers Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2021-2026)
Table 150. LG Life Sciences Main Business
Table 151. LG Life Sciences Latest Developments
LIST OF FIGURES
Figure 1. Picture of Travelers Vaccines
Figure 2. Travelers Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Travelers Vaccines Sales Growth Rate 2021-2032 (K Doses)
Figure 7. Global Travelers Vaccines Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Travelers Vaccines Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Travelers Vaccines Sales Market Share by Country/Region (2025)
Figure 10. Travelers Vaccines Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Meningococcal Vaccine
Figure 12. Product Picture of Japanese Encephalitis Vaccine
Figure 13. Product Picture of Yellow Fever Vaccine
Figure 14. Product Picture of Hepatitis Vaccine
Figure 15. Product Picture of Cholera Vaccine
Figure 16. Product Picture of Other
Figure 17. Global Travelers Vaccines Sales Market Share by Type in 2026
Figure 18. Global Travelers Vaccines Revenue Market Share by Type (2021-2026)
Figure 19. Product Picture of Mandatory Vaccination
Figure 20. Product Picture of Recommended Vaccination
Figure 21. Product Picture of Routine Booster
Figure 22. Global Travelers Vaccines Sales Market Share by Vaccination Purpose in 2026
Figure 23. Global Travelers Vaccines Revenue Market Share by Vaccination Purpose (2021-2026)
Figure 24. Product Picture of Travel Clinics
Figure 25. Product Picture of Public Hospitals
Figure 26. Product Picture of Private Providers
Figure 27. Global Travelers Vaccines Sales Market Share by End Channel in 2026
Figure 28. Global Travelers Vaccines Revenue Market Share by End Channel (2021-2026)
Figure 29. Travelers Vaccines Consumed in Tourists
Figure 30. Global Travelers Vaccines Market: Tourists (2021-2026) & (K Doses)
Figure 31. Travelers Vaccines Consumed in Students
Figure 32. Global Travelers Vaccines Market: Students (2021-2026) & (K Doses)
Figure 33. Travelers Vaccines Consumed in Workers
Figure 34. Global Travelers Vaccines Market: Workers (2021-2026) & (K Doses)
Figure 35. Travelers Vaccines Consumed in Others
Figure 36. Global Travelers Vaccines Market: Others (2021-2026) & (K Doses)
Figure 37. Global Travelers Vaccines Sale Market Share by End Users (2025)
Figure 38. Global Travelers Vaccines Revenue Market Share by End Users in 2025
Figure 39. Travelers Vaccines Sales by Company in 2025 (K Doses)
Figure 40. Global Travelers Vaccines Sales Market Share by Company in 2025
Figure 41. Travelers Vaccines Revenue by Company in 2025 ($ millions)
Figure 42. Global Travelers Vaccines Revenue Market Share by Company in 2025
Figure 43. Global Travelers Vaccines Sales Market Share by Geographic Region (2021-2026)
Figure 44. Global Travelers Vaccines Revenue Market Share by Geographic Region in 2025
Figure 45. Americas Travelers Vaccines Sales 2021-2026 (K Doses)
Figure 46. Americas Travelers Vaccines Revenue 2021-2026 ($ millions)
Figure 47. APAC Travelers Vaccines Sales 2021-2026 (K Doses)
Figure 48. APAC Travelers Vaccines Revenue 2021-2026 ($ millions)
Figure 49. Europe Travelers Vaccines Sales 2021-2026 (K Doses)
Figure 50. Europe Travelers Vaccines Revenue 2021-2026 ($ millions)
Figure 51. Middle East & Africa Travelers Vaccines Sales 2021-2026 (K Doses)
Figure 52. Middle East & Africa Travelers Vaccines Revenue 2021-2026 ($ millions)
Figure 53. Americas Travelers Vaccines Sales Market Share by Country in 2025
Figure 54. Americas Travelers Vaccines Revenue Market Share by Country (2021-2026)
Figure 55. Americas Travelers Vaccines Sales Market Share by Type (2021-2026)
Figure 56. Americas Travelers Vaccines Sales Market Share by End Users (2021-2026)
Figure 57. United States Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 58. Canada Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 59. Mexico Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 60. Brazil Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 61. APAC Travelers Vaccines Sales Market Share by Region in 2025
Figure 62. APAC Travelers Vaccines Revenue Market Share by Region (2021-2026)
Figure 63. APAC Travelers Vaccines Sales Market Share by Type (2021-2026)
Figure 64. APAC Travelers Vaccines Sales Market Share by End Users (2021-2026)
Figure 65. China Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 66. Japan Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 67. South Korea Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 68. Southeast Asia Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 69. India Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 70. Australia Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 71. China Taiwan Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 72. Europe Travelers Vaccines Sales Market Share by Country in 2025
Figure 73. Europe Travelers Vaccines Revenue Market Share by Country (2021-2026)
Figure 74. Europe Travelers Vaccines Sales Market Share by Type (2021-2026)
Figure 75. Europe Travelers Vaccines Sales Market Share by End Users (2021-2026)
Figure 76. Germany Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 77. France Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 78. UK Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 79. Italy Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 80. Russia Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 81. Middle East & Africa Travelers Vaccines Sales Market Share by Country (2021-2026)
Figure 82. Middle East & Africa Travelers Vaccines Sales Market Share by Type (2021-2026)
Figure 83. Middle East & Africa Travelers Vaccines Sales Market Share by End Users (2021-2026)
Figure 84. Egypt Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 85. South Africa Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 86. Israel Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 87. Turkey Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 88. GCC Countries Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 89. Manufacturing Cost Structure Analysis of Travelers Vaccines in 2026
Figure 90. Manufacturing Process Analysis of Travelers Vaccines
Figure 91. Industry Chain Structure of Travelers Vaccines
Figure 92. Channels of Distribution
Figure 93. Global Travelers Vaccines Sales Market Forecast by Region (2027-2032)
Figure 94. Global Travelers Vaccines Revenue Market Share Forecast by Region (2027-2032)
Figure 95. Global Travelers Vaccines Sales Market Share Forecast by Type (2027-2032)
Figure 96. Global Travelers Vaccines Revenue Market Share Forecast by Type (2027-2032)
Figure 97. Global Travelers Vaccines Sales Market Share Forecast by End Users (2027-2032)
Figure 98. Global Travelers Vaccines Revenue Market Share Forecast by End Users (2027-2032)
Figure 1. Picture of Travelers Vaccines
Figure 2. Travelers Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Travelers Vaccines Sales Growth Rate 2021-2032 (K Doses)
Figure 7. Global Travelers Vaccines Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Travelers Vaccines Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Travelers Vaccines Sales Market Share by Country/Region (2025)
Figure 10. Travelers Vaccines Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Meningococcal Vaccine
Figure 12. Product Picture of Japanese Encephalitis Vaccine
Figure 13. Product Picture of Yellow Fever Vaccine
Figure 14. Product Picture of Hepatitis Vaccine
Figure 15. Product Picture of Cholera Vaccine
Figure 16. Product Picture of Other
Figure 17. Global Travelers Vaccines Sales Market Share by Type in 2026
Figure 18. Global Travelers Vaccines Revenue Market Share by Type (2021-2026)
Figure 19. Product Picture of Mandatory Vaccination
Figure 20. Product Picture of Recommended Vaccination
Figure 21. Product Picture of Routine Booster
Figure 22. Global Travelers Vaccines Sales Market Share by Vaccination Purpose in 2026
Figure 23. Global Travelers Vaccines Revenue Market Share by Vaccination Purpose (2021-2026)
Figure 24. Product Picture of Travel Clinics
Figure 25. Product Picture of Public Hospitals
Figure 26. Product Picture of Private Providers
Figure 27. Global Travelers Vaccines Sales Market Share by End Channel in 2026
Figure 28. Global Travelers Vaccines Revenue Market Share by End Channel (2021-2026)
Figure 29. Travelers Vaccines Consumed in Tourists
Figure 30. Global Travelers Vaccines Market: Tourists (2021-2026) & (K Doses)
Figure 31. Travelers Vaccines Consumed in Students
Figure 32. Global Travelers Vaccines Market: Students (2021-2026) & (K Doses)
Figure 33. Travelers Vaccines Consumed in Workers
Figure 34. Global Travelers Vaccines Market: Workers (2021-2026) & (K Doses)
Figure 35. Travelers Vaccines Consumed in Others
Figure 36. Global Travelers Vaccines Market: Others (2021-2026) & (K Doses)
Figure 37. Global Travelers Vaccines Sale Market Share by End Users (2025)
Figure 38. Global Travelers Vaccines Revenue Market Share by End Users in 2025
Figure 39. Travelers Vaccines Sales by Company in 2025 (K Doses)
Figure 40. Global Travelers Vaccines Sales Market Share by Company in 2025
Figure 41. Travelers Vaccines Revenue by Company in 2025 ($ millions)
Figure 42. Global Travelers Vaccines Revenue Market Share by Company in 2025
Figure 43. Global Travelers Vaccines Sales Market Share by Geographic Region (2021-2026)
Figure 44. Global Travelers Vaccines Revenue Market Share by Geographic Region in 2025
Figure 45. Americas Travelers Vaccines Sales 2021-2026 (K Doses)
Figure 46. Americas Travelers Vaccines Revenue 2021-2026 ($ millions)
Figure 47. APAC Travelers Vaccines Sales 2021-2026 (K Doses)
Figure 48. APAC Travelers Vaccines Revenue 2021-2026 ($ millions)
Figure 49. Europe Travelers Vaccines Sales 2021-2026 (K Doses)
Figure 50. Europe Travelers Vaccines Revenue 2021-2026 ($ millions)
Figure 51. Middle East & Africa Travelers Vaccines Sales 2021-2026 (K Doses)
Figure 52. Middle East & Africa Travelers Vaccines Revenue 2021-2026 ($ millions)
Figure 53. Americas Travelers Vaccines Sales Market Share by Country in 2025
Figure 54. Americas Travelers Vaccines Revenue Market Share by Country (2021-2026)
Figure 55. Americas Travelers Vaccines Sales Market Share by Type (2021-2026)
Figure 56. Americas Travelers Vaccines Sales Market Share by End Users (2021-2026)
Figure 57. United States Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 58. Canada Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 59. Mexico Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 60. Brazil Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 61. APAC Travelers Vaccines Sales Market Share by Region in 2025
Figure 62. APAC Travelers Vaccines Revenue Market Share by Region (2021-2026)
Figure 63. APAC Travelers Vaccines Sales Market Share by Type (2021-2026)
Figure 64. APAC Travelers Vaccines Sales Market Share by End Users (2021-2026)
Figure 65. China Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 66. Japan Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 67. South Korea Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 68. Southeast Asia Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 69. India Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 70. Australia Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 71. China Taiwan Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 72. Europe Travelers Vaccines Sales Market Share by Country in 2025
Figure 73. Europe Travelers Vaccines Revenue Market Share by Country (2021-2026)
Figure 74. Europe Travelers Vaccines Sales Market Share by Type (2021-2026)
Figure 75. Europe Travelers Vaccines Sales Market Share by End Users (2021-2026)
Figure 76. Germany Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 77. France Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 78. UK Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 79. Italy Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 80. Russia Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 81. Middle East & Africa Travelers Vaccines Sales Market Share by Country (2021-2026)
Figure 82. Middle East & Africa Travelers Vaccines Sales Market Share by Type (2021-2026)
Figure 83. Middle East & Africa Travelers Vaccines Sales Market Share by End Users (2021-2026)
Figure 84. Egypt Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 85. South Africa Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 86. Israel Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 87. Turkey Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 88. GCC Countries Travelers Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 89. Manufacturing Cost Structure Analysis of Travelers Vaccines in 2026
Figure 90. Manufacturing Process Analysis of Travelers Vaccines
Figure 91. Industry Chain Structure of Travelers Vaccines
Figure 92. Channels of Distribution
Figure 93. Global Travelers Vaccines Sales Market Forecast by Region (2027-2032)
Figure 94. Global Travelers Vaccines Revenue Market Share Forecast by Region (2027-2032)
Figure 95. Global Travelers Vaccines Sales Market Share Forecast by Type (2027-2032)
Figure 96. Global Travelers Vaccines Revenue Market Share Forecast by Type (2027-2032)
Figure 97. Global Travelers Vaccines Sales Market Share Forecast by End Users (2027-2032)
Figure 98. Global Travelers Vaccines Revenue Market Share Forecast by End Users (2027-2032)
